These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 2994046)
1. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Stocking C; Kollek R; Bergholz U; Ostertag W Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046 [TBL] [Abstract][Full Text] [Related]
2. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus. Stocking C; Kollek R; Bergholz U; Ostertag W Virology; 1986 Aug; 153(1):145-9. PubMed ID: 3016984 [TBL] [Abstract][Full Text] [Related]
3. The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene. Ostertag W; Seliger B; Kollek R; Stocking C; Bergholz U; Smadja-Joffe F J Gen Virol; 1986 Jul; 67 ( Pt 7)():1361-71. PubMed ID: 3014049 [TBL] [Abstract][Full Text] [Related]
5. Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues. Gojobori T; Yokoyama S Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4198-201. PubMed ID: 2987967 [TBL] [Abstract][Full Text] [Related]
6. Sequences in the long terminal repeats of the Moloney murine sarcoma virus-124 genome which control transforming gene function. Narayanan R; Srinivasan A; Aaronson SA Virology; 1984 Aug; 137(1):32-40. PubMed ID: 6089418 [TBL] [Abstract][Full Text] [Related]
7. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization. Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374 [TBL] [Abstract][Full Text] [Related]
8. Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos. Papkoff J; Ringold GM J Virol; 1984 Nov; 52(2):420-30. PubMed ID: 6092668 [TBL] [Abstract][Full Text] [Related]
10. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon. Sergiescu D; Gerfaux J; Joret AM; Chany C Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718 [TBL] [Abstract][Full Text] [Related]
11. Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors. Laker C; Gräning G; Kelso A; Stocking C; Ostertag W J Exp Med; 1990 Aug; 172(2):447-56. PubMed ID: 2165126 [TBL] [Abstract][Full Text] [Related]
12. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. Fusco A; Portella G; Di Fiore PP; Berlingieri MT; Di Lauro R; Schneider AB; Vecchio G J Virol; 1985 Oct; 56(1):284-92. PubMed ID: 2993656 [TBL] [Abstract][Full Text] [Related]
13. Alternate utilization of two regulatory domains within the Moloney murine sarcoma virus long terminal repeat. Graves BJ; Eisenberg SP; Coen DM; McKnight SL Mol Cell Biol; 1985 Aug; 5(8):1959-68. PubMed ID: 3018540 [TBL] [Abstract][Full Text] [Related]
14. Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene. Seliger B; Kollek R; Stocking C; Franz T; Ostertag W Mol Cell Biol; 1986 Jan; 6(1):286-93. PubMed ID: 3023829 [TBL] [Abstract][Full Text] [Related]
15. Enhanced transformation by a simian virus 40 recombinant virus containing a Harvey murine sarcoma virus long terminal repeat. Kriegler M; Botchan M Mol Cell Biol; 1983 Mar; 3(3):325-39. PubMed ID: 6302472 [TBL] [Abstract][Full Text] [Related]
16. Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. Gunther CV; Nye JA; Bryner RS; Graves BJ Genes Dev; 1990 Apr; 4(4):667-79. PubMed ID: 2163347 [TBL] [Abstract][Full Text] [Related]
17. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell. Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237 [TBL] [Abstract][Full Text] [Related]
18. Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis. Stacey A; Arbuthnott C; Kollek R; Coggins L; Ostertag W J Virol; 1984 Jun; 50(3):725-32. PubMed ID: 6328002 [TBL] [Abstract][Full Text] [Related]
19. Functions of the mos oncogene family and associated gene products. Bold RJ; Hannink M; Donoghue DJ Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405 [TBL] [Abstract][Full Text] [Related]
20. Tissue tropism of a leukemogenic murine retrovirus is determined by sequences outside of the long terminal repeats. Wolff L; Ruscetti S Proc Natl Acad Sci U S A; 1986 May; 83(10):3376-80. PubMed ID: 3010293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]